Non-small cell lung cancer detection using microRNA expression profiling of bronchoalveolar lavage fluid and sputum

Anticancer Res. 2015 Apr;35(4):1873-80.

Abstract

Aim: To assess if miRNA expression profiling of bronchoalveolar lavage (BAL) fluid and sputum could be used to detect early-stage non-small cell lung cancer (NSCLC).

Materials and methods: Hierarchical cluster analysis was performed on the expression levels of 5 miRNAs (miR-21, miR-143, miR-155, miR-210, and miR-372) which were quantified using RNA reverse transcription and quantitative real-time polymerase chain reaction in sputum and BAL samples from NSCLC cases and cancer-free controls.

Results: Cluster analysis of the miRNA expression levels in BAL samples from 21 NSCLC cases and sputum samples from 10 cancer-free controls yielded a diagnostic sensitivity of 85.7% and specificity of 100%. Cluster analysis of sputum samples from the same patients yielded a diagnostic sensitivity of 67.8% and specificity of 90%.

Conclusion: miRNA expression profiling of sputum and BAL fluids represent a potential means to detect early-stage NSCLC.

Keywords: Non-small cell lung cancer; bronchoalveolar lavage; cancer detection; micro RNA profiling; sputum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / isolation & purification
  • Bronchoalveolar Lavage Fluid
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • MicroRNAs / genetics*
  • MicroRNAs / isolation & purification
  • Middle Aged
  • Prognosis*
  • Sputum / metabolism

Substances

  • Biomarkers, Tumor
  • MicroRNAs